A high-cholesterol diet increases 27-hydroxycholesterol and modifies estrogen receptor expression and neurodegeneration in rabbit hippocampus

Journal of Alzheimer's Disease

Volumn 56, Issue 1, 2017, Pages 185-196

  Brooks, Sylwia W ^a,b   Dykes, Ava C ^c   Schreurs, Bernard G ^a,b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

27 hydroxycholesterol; Alzheimer's disease; Cholesterol; Cholesterol fed rabbit; ER ; ER ; Estrogen receptors; Mitochondria; Oxysterol; PSD 95; Synapse

Indexed keywords

27-HYDROXYCHOLESTEROL; CHOLESTEROL; CHOLESTEROL DERIVATIVE; DISKS LARGE HOMOLOG 4; ESTROGEN RECEPTOR; FLUORESCEIN DERIVATIVE; FLUORO-JADE C; MITOCHONDRIAL PROTEIN;

ANIMAL; BLOOD; CELL COUNT; CHEMICALLY INDUCED; CYTOLOGY; DEGENERATIVE DISEASE; DRUG EFFECTS; HIPPOCAMPUS; LEPORIDAE; LIPID DIET; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METABOLISM; NERVE CELL; PATHOLOGY;

ANIMALS; CELL COUNT; CHOLESTEROL; CHROMATOGRAPHY, LIQUID; DIET, HIGH-FAT; DISKS LARGE HOMOLOG 4 PROTEIN; FLUORESCEINS; HIPPOCAMPUS; HYDROXYCHOLESTEROLS; MALE; MASS SPECTROMETRY; MITOCHONDRIAL PROTEINS; NEURODEGENERATIVE DISEASES; NEURONS; RABBITS; RECEPTORS, ESTROGEN;

EID: 85027273203     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-160725     Document Type: Article

References (78)

1. Panza F, FrisardiV, Capurso C, Imbimbo BP,Vendemiale G, Santamato A, D'Onofrio G, Seripa D, Sancarlo D, Pilotto A, Solfrizzi V (2010) Metabolic syndrome and cognitive impairment: Current epidemiology and possible underlying mechanisms. J Alzheimers Dis 21, 691-724.
2. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Iivonen S, Mannermaa A, Tuomilehto J, Nissinen A, Soininen H (2002) Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med 137, 149-155.
3. Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA (2009) Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement Geriatr Cogn Disord 28, 75-80.
4. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP Jr,YaffeK(2005) Obesity in middle age and future risk of dementia: A 27 year longitudinal population based study. BMJ 330, 1360-1369
5. Luchsinger J, Gustafson D (2009) Adiposity and Alzheimer's disease. Curr Opin Clin Nutr Metab Care 12, 15-21.
6. Burns MP, Rebeck GW (2010) Intracellular cholesterol homeostasis and amyloid precursor protein processing. Biochim Biophys Acta 1801, 853-859.
7. Posse de Chaves E (2012) Reciprocal regulation of cholesterol and beta amyloid at the subcellular level in Alzheimer's disease. Can J Physiol Pharmacol 90, 753-764.
8. Maulik M, Westaway D, Jhamandas JH, Kar S (2013) Role of cholesterol in APP Metabolism and its significance in Alzheimer's Disease Pathogenesis. Mol Neurobiol 47, 37-63.
9. Ong WY, Tanaka K, Dawe GS, Ittner LM, Farooqui AA (2013) Slow excitotoxicity in Alzheimer's disease. J Alzheimers Dis 35, 643-668.
10. Fornicola W, Pelcovits A, Li BX, Heath J, Perry G, Castellani RJ (2014) Alzheimer disease pathology in middle age reveals a spatial-temporal disconnect between amyloid-beta and phosphorylated tau. Open Neurol J 8, 22-26.
11. Sparks DL, Scheff SW, Hunsaker JC III, Liu H, Landers T, Gross DR (1994) Induction of Alzheimer-like betaamyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol 126, 88-94.
12. Ghribi O, Larsen B, Schrag M, Herman MM (2006) High cholesterol content in neurons increases BACE, beta-amyloid, and phosphorylated tau levels in rabbit hippocampus. Exp Neurol 200, 460-467.
13. Jaya Prasanthi RP, Schommer E, Thomasson S, Thompson A, Feist G, Ghribi O (2008) Regulation of beta-amyloid levels in the brain of cholesterol-fed rabbit, a model system for sporadic Alzheimer's disease. Mech Ageing Dev 129, 649-655.
14. Lemieux SK, Smith-Bell CA,Wells JR, Ezerioha NM, Carpenter JS, Sparks DL, Schreurs BG (2010) Neurovascular changes measured by time-of-flight MR angiography in cholesterol-fed rabbits with cortical amyloid beta-peptide accumulation. J Magn Reson Imaging 32, 306-314.
15. Zhang DD, Yu HL, MaWW, Liu QR, Han J,Wang H, Xiao R (2015) 27-hydroxycholesterol contributes to disruptive effects on learning and memory by modulating cholesterol metabolism in the rat brain. Neuroscience 300, 163-173.
16. Heverin M, Maioli S, Pham T, Mateos L, Camporesi E, Ali Z, Winblad B, Cedazo-Minguez A, Bjorkhem I (2015) 27-hydroxycholesterol mediates negative effects of dietary cholesterol on cognition in mice. Behav Brain Res 278, 356-359.
17. Darwish DS, Wang D, Konat Gregory W, Schreurs BG (2010) Dietary cholesterol impairs memory and memory increases brain cholesterol and sulfatide levels. Behav Neurosci 124, 115-123.
18. Schreurs BG (2013) Cholesterol and copper affect learning and memory in the rabbit. Int J Alzheimers Dis 2013, 518780-518792.
19. Schreurs BG, Wang D, Smith-Bell CA, Burhans LB, Bell R, Gonzalez-Joekes J (2012) Dietary cholesterol concentration and duration degrade long-term memory of classical conditioning of the rabbit's nictitating membrane response. Int J Alzheimers Dis 2012, 732634-732644.
20. Schreurs BG, Smith-Bell CA, Wang D, Burhans LB (2013) Dietary cholesterol degrades rabbit long term memory for discrimination learning but facilitates acquisition of discrimination reversal. Neurobiol Learn Mem 106, 238-245.
21. Sparks DL, Schreurs BG (2003) Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc Natl Acad Sci U S A 100, 11065-11069.
22. Heverin M, Bogdanovic N, Lutjohann D, Bayer T, Pikuleva I, Bretillon L, Diczfalusy U,Winblad B, Bjorkhem I (2004) Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J Lipid Res 45, 186-193.
23. Marwarha G, Ghribi O (2015) Does the oxysterol 27-hydroxycholesterol underlie Alzheimer's disease-Parkinson's disease overlap? Exp Gerontol 68, 13-18.
24. Bjorkhem I, Cedazo-Minguez A, Leoni V, Meaney S (2009) Oxysterols and neurodegenerative diseases. Mol Aspects Med 30, 171-179.
25. DuSell CD, McDonnell DP (2008) 27-Hydroxycholesterol: A potential endogenous regulator of estrogen receptor signaling. Trends Pharmacol Sci 29, 510-514.
26. DuSell CD, Umetani M, Shaul PW, Mangelsdorf DJ, McDonnell DP (2008) 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator. Mol Endocrinol 22, 65-77.
27. DuSell CD, Nelson ER, Wang X, Abdo J, Modder UI, Umetani M, Gesty-Palmer D, Javitt NB, Khosla S, McDonnell DP (2010) The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis. Endocrinology 151, 3675-3685.
28. Nelson ER, Wardell SE, Jasper JS, Park S, Suchindran S, Howe MK, Carver NJ, Pillai RV, Sullivan PM, Sondhi V, Umetani M, Geradts J, McDonnell DP (2013) 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Science 342, 1094-1098.
29. Wu Q, Ishikawa T, Sirianni R, Tang H, McDonald JG, Yuhanna IS, Thompson B, Girard L, Mineo C, Brekken RA, Umetani M, Euhus DM, Xie Y, Shaul PW (2013) 27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth. Cell Rep 5, 637-645.
30. Umetani M, Domoto H, Gormley AK, Yuhanna IS, Cummins CL, Javitt NB, Korach KS, Shaul PW, Mangelsdorf DJ (2007) 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat Med 13, 1185-1192.
31. Umetani M, Shaul PW (2011) 27-Hydroxycholesterol: The first identified endogenous SERM. Trends Endocrinol Metab 22, 130-135.
32. Umetani M, Ghosh P, Ishikawa T, Umetani J, Ahmed M, Mineo C, Shaul PW (2014) The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha. Cell Metab 20, 172-182.
33. Braak H, Braak E, Bohl J (1993) Staging of Alzheimer-related cortical destruction. Eur Neurol 33, 403-408.
34. Schmued LC, Stowers CC, Scallet AC, Xu L (2005) Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res 1035, 24-31.
35. Ahonen L, Maire FBR, Savolainen M, Kopra J, Vreeken RJ, Hankemeier T, Myohanen T, Kylli P, Kostiainen R (2014) Analysis of oxysterols and vitamin D metabolites in mouse brain and cell line samples by ultra-highperformance liquid chromatography-atmospheric pressure photoionization-mass spectrometry. J Chromatogr A 1364, 214-222.
36. O'Neill RA, Bhamidipati A, Bi X, Deb-Basu D, Cahill L, Ferrante J, Gentalen E, Glazer M, Gossett J, Hacker K, Kirby C, Knittle J, Loder R, Mastroieni C, Maclaren M, Mills T, Nguyen U, Parker N, Rice A, Roach D, Suich D, Voehringer D, Voss K, Yang J, Yang T, Vander Horn PB (2006) Isoelectric focusing technology quantifies protein signaling in 25 cells. Proc Natl Acad Sci U S A 103, 16153-16158.
37. Beccano-Kelly DA, Kuhlmann N, Tatarnikov I, Volta M, Munsie LN, Chou P, Cao LP, Han H, Tapia L, Farrer MJ, Milnerwood AJ (2014) Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice. Front Cell Neurosci 8, 301-312
38. Hartz AM, Zhong Y, Wolf A, LeVine H, III, Miller DS, Bauer B (2016) Amyloid-beta 40 reduces p-glycoprotein at the blood-brain barrier through the ubiquitin-proteasome pathway. J Neurosci 36, 1930-1941.
39. Prasanthi JR, Dasari B, Marwarha G, Larson T, Chen X, Geiger JD, Ghribi O (2010) Caffeine protects against oxidative stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet. Free Radic Biol Med 49, 1212-1220.
40. Deci S, Lemieux SK, Smith-Bell CA, Sparks DL, Schreurs BG (2012) Cholesterol increases ventricular volume in a rabbit model of Alzheimer's disease. J Alzheimers Dis 29, 283-292.
41. Richner M, Bach G, West MJ (2009) Over expression of amyloid beta-protein reduces the number of neurons in the striatum of APPswe/PS1DeltaE9. Brain Res 1266, 87-92.
42. West MJ, Bach G, Soderman A, Jensen JL (2009) Synaptic contact number and size in stratum radiatum CA1 of APP/PS1DeltaE9 transgenic mice. Neurobiol Aging 30, 1756-1776.
43. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706.
44. St George-Hyslop PH, Tanzi RE, Polinsky RJ, Haines JL, Nee L, Watkins PC, Myers RH, Feldman RG, Pollen D, Drachman D (1987) The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 235, 885-890.
45. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin JF, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HA, Haines JL, Perkicak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
46. St George-Hyslop P, Haines J, Rogaev E,Mortilla M, Vaula G, Pericak-Vance M, Foncin JF, Montesi M, Bruni A, Sorbi S, Rainero I, Pinessi L, Pollen D, Polinsky R, Nee L, Kennedy J, Macciardi F, Rogaeva E, Liang Y, Alexandrova N, Lukiw W, Schlumpf K, Tanzi R, Tsuda T, Farrer L, Cantu JM, Duara R, Amaducci L, Bergamini L, Gusella J, Roses A, Crapper MD (1992) Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat Genet 2, 330-334.
47. Van BC, Backhovens H, Cruts M, De WG, Bruyland M, Cras P, Martin JJ (1992) Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3. Nat Genet 2, 335-339.
48. Sherrington R, Froelich S, Sorbi S, Campion D, Chi H, Rogaeva EA, Levesque G, Rogaev EI, Lin C, Liang Y, Ikeda M, Mar L, Brice A, Agid Y, Percy ME, Clerget-Darpoux F, Piacentini S, Marcon G, Nacmias B, Amaducci L, Frebourg T, Lannfelt L, Rommens JM, St George-Hyslop PH (1996) Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum Mol Genet 5, 985-988.
49. Benilova I, Karran E, De SB (2012) The toxic Abeta oligomer and Alzheimer's disease: An emperor in need of clothes. Nat Neurosci 15, 349-357.
50. Castello MA, Soriano S (2014) On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis. Ageing Res Rev 13, 10-12.
51. Lutjohann D, Papassotiropoulos A, Bjorkhem I, Locatelli S, Bagli M, Oehring RD, Schlegel U, Jessen F, Rao ML, von BK, Heun R (2000) Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J Lipid Res 41, 195-198.
52. Mateos L, Ismail MA, Gil-Bea FJ, Leoni V, Winblad B, Bjorkhem I, Cedazo-Minguez A (2011) Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimer's disease. J Alzheimers Dis 24, 669-679.
53. Hughes TM, Rosano C, Evans RW, Kuller LH (2013) Brain cholesterol metabolism, oxysterols, and dementia. J Alzheimers Dis 33, 891-911.
54. Hughes TM, Kuller LH, Lopez OL, Becker JT, Evans RW, Sutton-Tyrrell K, Rosano C (2012) Markers of cholesterol metabolism in the brain show stronger associations with cerebrovascular disease than Alzheimer's disease. J Alzheimers Dis 30, 53-61.
55. Zuliani G, Donnorso MP, Bosi C, Passaro A, Dalla NE, Zurlo A, Bonetti F, MozziAF, CorteseC(2011) Plasma 24Shydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: A case-control study. BMC Neurol 11, 121-129
56. Beach TG, Maarouf CL, Brooks RG, Shirohi S, Daugs ID, Sue LI, Sabbagh MN, Walker DG, Lue L, Roher AE (2011) Reduced clinical and postmortem measures of cardiac pathology in subjects with advanced Alzheimer's Disease. BMC Geriatr 11, 1-7
57. Sparks DL, Hunsaker JC, III, Scheff SW, Kryscio RJ, Henson JL, Markesbery WR (1990) Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol Aging 11, 601-607.
58. Nelson ER, DuSell CD, Wang X, Howe MK, Evans G, Michalek RD, Umetani M, Rathmell JC, Khosla S, Gesty-Palmer D, McDonnell DP (2011) The oxysterol, 27-hydroxycholesterol, links cholesterol metabolism to bone homeostasis through its actions on the estrogen and liver X receptors. Endocrinology 152, 4691-4705.
59. Sparks DL (2008) The early and ongoing experience with the cholesterol-fed rabbit as a model of Alzheimer's disease: The old, the newand the pilot. J Alzheimers Dis 15, 641-656.
60. McEwen BS, Gould E, Orchinik M, Weiland NG, Woolley CS (1995) Oestrogens and the structural and functional plasticity of neurons: Implications for memory, ageing and neurodegenerative processes. Ciba Found Symp 191, 52-66.
61. Hara Y, Waters EM, McEwen BS, Morrison JH (2015) Estrogen effects on cognitive and synaptic health over the lifecourse. Physiol Rev 95, 785-807.
62. Han X, Aenlle KK, Bean LA, Rani A, Semple-Rowland SL, Kumar A, Foster TC (2013) Role of estrogen receptor alpha and beta in preserving hippocampal function during aging. J Neurosci 33, 2671-2683.
63. McEwen BS, Akama KT, Spencer-Segal JL, Milner TA, Waters EM (2012) Estrogen effects on the brain: Actions beyond the hypothalamus via novel mechanisms. Behav Neurosci 126, 4-16.
64. Foster TC (2012) Role of estrogen receptor alpha and beta expression and signaling on cognitive function during aging. Hippocampus 22, 656-669.
65. Brookmeyer R, Evans DA, Hebert L, Langa KM, Heeringa SG, Plassman BL, KukullWA (2011) National estimates of the prevalence of Alzheimer's disease in the United States. Alzheimers Dement 7, 61-73.
66. Chapman RM, Mapstone M, Gardner MN, Sandoval TC, McCrary JW, Guillily MD, Reilly LA, DeGrush E (2011) Women have farther to fall: Gender differences between normal elderly and Alzheimer's disease in verbal memory engender better detection of Alzheimer's disease in women. J Int Neuropsychol Soc 17, 654-662.
67. Irvine K, Laws KR, Gale TM, Kondel TK (2012) Greater cognitive deterioration in women than men with Alzheimer's disease: A meta analysis. J Clin Exp Neuropsychol 34, 989-998.
68. Zhao L, Mao Z, Woody SK, Brinton RD (2016) Sex differences in metabolic aging of the brain: Insights into female susceptibility to Alzheimer's disease. Neurobiol Aging 42, 69-79.
69. Qu J, Liu W, Huang C, Xu C, Du G, Gu A, Wang X (2014) Estrogen receptors are involved in polychlorinated biphenyl-induced apoptosis on mouse spermatocyte GC-2 cell line. Toxicol In Vitro 28, 373-380.
70. Zhang QG, Han D,Wang RM, Dong Y, Yang F, Vadlamudi RK, Brann DW (2011) C terminus of Hsc70-interacting protein (CHIP)-mediated degradation of hippocampal estrogen receptor-alpha and the critical period hypothesis of estrogen neuroprotection. Proc Natl Acad Sci U S A 108, E617-E624.
71. Srivastava DP, Woolfrey KM, Penzes P (2013) Insights into rapid modulation of neuroplasticity by brain estrogens. Pharmacol Rev 65, 1318-1350.
72. Gould E, Woolley CS, Frankfurt M, McEwen BS (1990) Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 10, 1286-1291.
73. Phan A, Lancaster KE, Armstrong JN, MacLusky NJ, Choleris E (2011) Rapid effects of estrogen receptor alpha and beta selective agonists on learning and dendritic spines in female mice. Endocrinology 152, 1492-1502.
74. Szymczak S, Kalita K, Jaworski J, Mioduszewska B, Savonenko A, Markowska A, Merchenthaler I, Kaczmarek L (2006) Increased estrogen receptor beta expression correlates with decreased spine formation in the rat hippocampus. Hippocampus 16, 453-463.
75. Merlo S, Spampinato SF, Capani F, Sortino MA (2016) Early beta-amyloid-induced synaptic dysfunction is counteracted by estrogen in organotypic hippocampal cultures. Curr Alzheimer Res 13, 631-640.
76. Fester L, Labitzke J, Hinz R, Behem C, Horling K, Bernhard T, Bader MI, Vollmer G, Rune GM (2013) Estradiol responsiveness of synaptopodin in hippocampal neurons is mediated by estrogen receptor beta. J Steroid Biochem Mol Biol 138, 455-461.
77. Yang SH, Sarkar SN, Liu R, Perez EJ, Wang X, Wen Y, Yan LJ, Simpkins JW (2009) Estrogen receptor beta as a mitochondrial vulnerability factor. J Biol Chem 284, 9540-9548.
78. Mateos L, Ismail MA, Gil-Bea FJ, Schule R, Schols L, Heverin M, Folkesson R, Bjorkhem I, Cedazo-Minguez A (2011) Side chain-oxidized oxysterols regulate the brain renin-angiotensin system through a liver X receptordependent mechanism. J Biol Chem 286, 25574-25585.